Institutions / Great Point Partners, LLC / Holdings
Back to Great Point Partners, LLC

Great Point Partners, LLC

All holdings · as of Mar 31, 2026

39 positions

CompanyClassValue ↓Shares% of portfolio
Apogee Therapeutics, Inc.—$31.48M374,0007.7%
Vor Biopharma Inc.—$31.22M1,750,0007.6%
Zura Bio Limited—$25.08M4,215,9306.1%
Amylyx Pharmaceuticals, Inc.—$24.32M1,750,0006.0%
NEKTAR THERAPEUTICS—$22.77M316,4535.6%
Sol-Gel Technologies Ltd—$21.74M274,3635.3%
ALUMIS INC.ALMSCommon Stock$18.86M856,0614.6%
BRIGHT MINDS BIOSCIENCES INC.—$16.05M220,0003.9%
Annexon, Inc.—$13.85M2,500,0003.4%
KalVista Pharmaceuticals Inc—$13.59M675,0003.3%
Immunovant, Inc.IMVTCommon Stock$13.55M545,6253.3%
JADE BIOSCIENCES, INC.—$13.55M964,4623.3%
Contineum Therapeutics, Inc.—$10.45M800,1982.6%
Zenas BioPharma, Inc.ZBIOCommon Stock$10.25M524,0662.5%
Neurogene Inc.NGNECommon Stock$10.08M500,0002.5%
MoonLake ImmunotherapeuticsMLTXCommon Stock$9.32M500,0002.3%
Climb Bio, Inc.CLYMCommon Stock$9.14M1,334,1302.2%
Oruka Therapeutics, Inc.—$8.99M183,3302.2%
EUPRAXIA PHARMACEUTICALS INC.—$8.69M1,200,0002.1%
Vera Therapeutics, Inc.—$8.02M199,3482.0%
Evommune, Inc.EVMNCommon Stock$7.47M325,0001.8%
LB PHARMACEUTICALS INCLBRXCommon Stock$7.40M300,0001.8%
Compass Therapeutics, Inc.—$7.14M1,350,0001.7%
SCYNEXIS, Inc.—$6.93M7,554,3471.7%
PALISADE BIO, INC.—$5.96M3,405,7571.5%
Context Therapeutics Inc.—$5.86M2,238,4961.4%
Relmada Therapeutics, Inc.—$5.86M842,1061.4%
Silence Therapeutics plcSLNADR$5.38M1,020,4891.3%
Unicycive Therapeutics, Inc.—$5.24M796,5581.3%
Tenax Therapeutics, Inc.—$5.23M327,3071.3%
ProMIS Neurosciences, Inc.—$4.72M371,4021.2%
Cullinan Therapeutics, Inc.—$4.26M300,0001.0%
Immix Biopharma, Inc.—$3.19M350,0000.8%
Rezolute, Inc.—$2.90M951,8090.7%
Pharvaris N.V.—$2.34M82,8000.6%
HUMACYTE INC—$2.28M3,750,0000.6%
Avalo Therapeutics, Inc.—$1.86M124,6660.5%
Alkermes plc.—$1.77M50,0000.4%
Opus Genetics, Inc.—$1.48M324,3400.4%
← PrevPage 1 of 1Next →